Document Detail


ICP monitoring: complications and associated factors.
MedLine Citation:
PMID:  975699     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. Patients with complications when compared with those not developing a complication: a. Were older, 44.4 vs. 34.5 years; b. Were monitored longer, 14.0 vs. 6.5 days; c. Were treated with steroids longer, 18.3 vs. 10.3 days; d. Were hospitalized longer, 35.7 vs. 27.7 days; e. Are twice as likely to die; f. Average age of those dying is older, 46 vs. 30 years; g. Have no clear relationship to antibiotics; h. Do not have a preponderance of single diagnostic category to account for these differences; i. Complications were always controlled with standard therapy; j. An ICP complication was almost never responsible, per se, for death. 2. Over all complication rate was 18%; due to monitoring was 4.5 to 11.5%. 3. Monitoring was responsible for, or contributed to, 25 to 60% of the complications. 4. No complications occurred when monitoring was discontinued within 3 days. 5. Long periods of treatment with steroids increased the risk of a complication developing. 6. Long periods of monitoring were associated with an increased risk of complication. 7. "Individual" factors are partly responsible for the development of a complication, and death. 8. There are two groups of complications: "early" and "late." A. Those most likely to be monitor related occur "late" and account for 35% of the complications. B. Those developing "early" infection account for 65% of the complications and are most likely caused by factors other than monitoring. While there are complications directly attributable to monitoring, the rate is low and they are readily controlled by standard neurosurgical management. While monitoring may increase the morbidity, it does not increase the mortality. We feel that the over-all risk is small and that the returns are great--both in terms of knowledge and patient benefit.
Authors:
M J Rosner; D P Becker
Related Documents :
19295189 - Treatment of mediastinal fibrosis with mycophenolate mofetil.
24882459 - Recovery of vocal fold immobility following isolated patent ductus arteriosus ligation.
15204149 - Comparison of short- and long-term cyclosporine a therapy in chronic idiopathic urticaria.
17365909 - Predictive factors of clinical outcome in patients with diffuse proliferative lupus nep...
11275629 - Adult-onset minimal change disease among taiwanese: clinical features, therapeutic resp...
24734279 - Differential release kinetics of cardiac biomarkers in patients undergoing valve replac...
17968599 - Clinical evaluation of a polyacid-modified resin composite (dyract) in class v carious ...
22277879 - Effects of the per diem prospective payment system with drg-like grouping system (dpc/p...
22878279 - Weight gain after lung reduction surgery is related to improved lung function and venti...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical neurosurgery     Volume:  23     ISSN:  0069-4827     ISO Abbreviation:  Clin Neurosurg     Publication Date:  1976  
Date Detail:
Created Date:  1976-12-23     Completed Date:  1976-12-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985141R     Medline TA:  Clin Neurosurg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  494-519     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Anti-Bacterial Agents / therapeutic use
Brain Diseases / mortality
Brain Injuries / mortality
Catheterization / adverse effects
Craniotomy / adverse effects
Humans
Infection / etiology
Intracranial Pressure*
Meningitis / etiology
Monitoring, Physiologic* / adverse effects
Postoperative Complications
Steroids / therapeutic use
Time Factors
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Steroids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complications of surgery for subdural hematoma.
Next Document:  Radical surgical treatment of craniopharyngioma.